Why is Thyrocare Tech. falling/rising?

As of 25-Aug, Thyrocare Technologies Ltd is experiencing a slight increase in its stock price, currently at 1,265.00, with a change of 2.6 (0.21%) upwards. Today's price summary indicates that the stock has outperformed its sector by 0.85% and has shown a trend reversal after four consecutive days of decline, reaching an intraday high of Rs 1305.55. Despite a negative performance over the past week and month, with declines of 9.62% and 3.66% respectively, the stock has demonstrated strong year-to-date and annual returns of 38.60% and 40.25%. The company has reported high management efficiency, a low debt-to-equity ratio, and significant growth in net profit, which has contributed positively to its recent performance. However, concerns about long-term growth and high valuation metrics, such as a PEG ratio of 1.7 and 100% of promoter shares being pledged, may pose risks to its price stability.
Broader market context shows that while Thyrocare Technologies Ltd has outperformed the BSE500 index over the last year and three years, its recent short-term performance has lagged behind the benchmark, which has seen a modest increase of 0.45% over the past week. The stock's liquidity remains adequate for trading, and rising investor participation, as indicated by increased delivery volume, suggests a growing interest in the stock despite its recent volatility. Overall, while the stock is currently rising, the mixed signals from its performance metrics and market conditions indicate that investors should remain cautious.